Advanced Medical Optics shareholder ValueAct agrees to support merger with Abbott

By Lisa Kerner

Charlotte, N.C., Jan. 14 - ValueAct Capital Master Fund, LP and its affiliates agreed to tender all of their shares of Advanced Medical Optics, Inc. in Abbott Laboratories' previously announced $22-per-share offer for the company.

According to a schedule 13D/A filed with the Securities and Exchange Commission, ValueAct entered the tender and support agreement with Abbott as an inducement to Abbott entering the merger agreement with Advanced Medical Optics.

ValueAct beneficially owns 8,811,635 shares, or 14.3%, of Advanced Medical Optics' outstanding shares, the filing said.

On Monday, Abbott announced it would acquire Advanced Medical Optics in a transaction valued at $2.8 billion, including net debt.

Abbott is a biopharmaceutical company located in Abbott Park, Ill.

Santa Ana, Calif.-based Advanced Medical Optics operates in three segments: cataract surgery, Lasik and eye-care products.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.